Spelling suggestions: "subject:"tumour""
11 |
The clinical perspective on malignancies in renal transplanted patientsHellström, Vivan January 2016 (has links)
Post-transplant malignancies cause significant morbidity and mortality. In this thesis we investigated malignancies in renal transplanted patients from a clinical viewpoint. The use of regional tumour registries considerably improved identification of pre- and post-transplant malignancies, which are generally underreported in transplant registries. Despite previously adequate cancer treatments with favourable prognosis, patients with pre-transplant malignancies showed higher incidence of post-transplant cancer and reduced survival compared to a 1:3 ratio matched control group of patients without a previous cancer from the Collaborative Transplant Study in Europe. A careful oncological surveillance pre-transplant and post-transplant is recommended. A multidisciplinary team evaluated the immunosuppressive and oncological treatment in a clinical prospective observational study of 120 renal transplanted patients with post-transplant malignancies. In two-thirds of the patients immunosuppression was possible to change to mTOR inhibitors with anti-tumour effects. Oncological treatment was adjusted in 50% of patients with solid or haematological tumours. MDT assessments are essential for optimizing treatment of post-transplant malignancies. Number of previous cutaneous squamous cell carcinoma (SCC) posed the most significant risk variable in predicting subsequent SCCs during a two-years study of 73 transplanted patients with at least one SCC. Incidence of transplant-derived tumours is 5 times higher than anticipated. Three of eleven cancers in urinary tract and two of four cancers in the transplants were transplant-derived. Five of eleven cancers of the urinary tract were BK-virus positive. Allograft immune response against these tumours offer new options for cancer treatment such as immunomodulatory or anti-viral treatment in combination with modified immunosuppression.
|
12 |
Investigations of putative tumour suppressor loci in human malignancyBruce, Christopher Kenneth January 2001 (has links)
No description available.
|
13 |
The role of transcription factor AP-1 and gelatinases in oral carcinogenesis and their regulation by transforming growth factor betaRobinson, Conrad Maxwell January 1999 (has links)
No description available.
|
14 |
A study of childhood rhabdomyosarcoma with respect to diagnosis, prognosis and histogenesisDias, Peter Bento Ernest January 1989 (has links)
No description available.
|
15 |
Evaluation of mechanisms underlying the proliferative and invasive behaviour of gliomaKoochekpour, Shahriar January 1996 (has links)
No description available.
|
16 |
Cell lineage analysis of the liver and the intestinal epithelium of the mouseO'Sullivan, John F. January 1990 (has links)
No description available.
|
17 |
Proton nuclear magnetic resonance studies of human glioma cell linesFlorian, Catarina Ligia January 1996 (has links)
No description available.
|
18 |
Transcriptional regulation by Brn 3 POU domain containing transcription factorsDennis, Jonathan Hancock January 2001 (has links)
No description available.
|
19 |
Defective mismatch repair and DNA damage sensing in human cellsO'Driscoll, Mark John January 1999 (has links)
No description available.
|
20 |
Monoclonal antibodies for the study of colorectal and other carcinomasMakin, Carol Audrey January 1985 (has links)
No description available.
|
Page generated in 0.0409 seconds